BPC-157: Why Your Biohack Might Be a Regulatory Minefield
Smart founders chasing an edge often encounter BPC-157. This episode exposes its murky science, uncertain safety, and complex regulatory shell game.
Peptides: The Science, Uses & Safety | Dr. Abud Bakri
With Andrew Huberman, Dr. Abud Bakri · Sunday, June 7, 2026
This episode features Andrew Huberman and Dr. Abud Bakri, an internal medicine physician, in a masterclass discussion on peptides. They explore various categories of peptides, including FDA-approved GLP-1 agonists and non-FDA approved compounds like BPC-157, pinealon (EDR), GHK-Cu, and thymus peptides. The conversation delves into the science, mechanisms, safety profiles, anecdotal uses, and complex regulatory landscape surrounding these compounds, highlighting sourcing challenges and the ethical dilemmas clinicians face.
GLP-1s: The Hidden Costs, Ethical Traps, and Brain Unknowns
GLP-1 drugs promise weight loss, but Huberman and Bakri reveal shocking costs, ethical clinician profit, and critical long-term brain risks for founders. Don't leap before you look.
Growth Hormone Secretagogues: Muscle, Recovery, and a Hidden Risk?
GH secretagogues like MK677 promise muscle and recovery, but Huberman Lab reveals a stark trade-off: insulin sensitivity and cancer risk.
Peptide Supply Chain: Why Your 'Research Only' Vial Is a Minefield
Andrew Huberman and Dr. Abud Bakri expose the murky peptide market, from Chinese APIs to dangerous 'research only' vials. Founders, know your supply chain.
Your Thymus Gland Died at Puberty: What Now?
The thymus, vital for immunity, shrivels post-puberty. Learn how peptides like Thymosin Alpha 1 offer a path to regenerate it and boost resilience.